Literature DB >> 31806962

Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy.

Liren Zhang1, Peng Yang1, Ranran Guo1, Jiaxin Sun1, Ruihong Xie1, Wuli Yang1.   

Abstract

BACKGROUND: Chemo-photothermal therapy has attracted intensive attention because of its low side effects and better therapeutic efficiency. Although many photothermal agents have been loaded with chemotherapeutic drugs for chemo-photothermal therapy, their applications are limited by complex synthetic protocols and long-term safety. Therefore, there is significant clinical value in the development of a simple system of biocompatible and biodegradable photothermal nanomaterials with high payloads of chemotherapeutic drugs for chemo-photothermal synergistic therapy.
MATERIALS AND METHODS: In this study, PEG-modified polydopamine nanoparticles with mesoporous structure (MPDA-PEG) were successfully obtained by an emulsion-induced interface assembly strategy. Subsequently, paclitaxel (PTX) dissolved in acetone was loaded into the mesoporous channels of MPDA-PEG nanoparticles by solution absorption method. A PTX-loaded MPDA-PEG (MPDA-PEG-PTX) nanoplatform for combination of photothermal therapy (PTT) and chemotherapy was developed.
RESULTS: The synthesized MPDA-PEG nanoparticles had a great photothermal effect under near-infrared (NIR) laser irradiation and exhibited an enhanced photothermal effect with the increase of particle size. Meanwhile, MPDA-PEG nanoparticles also had a high payload of PTX, and the PTX release could be greatly accelerated by elevated temperature from photothermal effect. In MTT cytotoxicity assay, A549 cells incubated with MPDA-PEG-PTX under NIR laser irradiation (PTT + chemotherapy group) exhibited better therapeutic effect than single chemotherapy (MPDA-PEG-PTX group) and PTT (MPDA-PEG + Laser group). The synergistic therapeutic effect of MPDA-PEG-PTX with NIR laser irradiation in vivo was further investigated under the guidance of photoacoustic imaging (PAI), tumors of nude mice treated with MPDA-PEG-PTX with NIR laser irradiation were completely eliminated with minimal side effect.
CONCLUSION: The MPDA-PEG-PTX nanoplatform is a simple and effective platform which can completely inhibit tumor growth with minimal side effects under NIR irradiation, and it exhibits better therapeutic effect than single chemotherapy and PTT.
© 2019 Zhang et al.

Entities:  

Keywords:  chemotherapy; mesoporous nanoparticle; paclitaxel; photothermal therapy; polydopamine

Mesh:

Substances:

Year:  2019        PMID: 31806962      PMCID: PMC6839591          DOI: 10.2147/IJN.S218632

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  44 in total

1.  Microscale Heat Transfer Transduced by Surface Plasmon Resonant Gold Nanoparticles.

Authors:  D Keith Roper; W Ahn; M Hoepfner
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2007-09       Impact factor: 4.126

2.  Ultrastructural and optical characteristics of cancer cells treated by a nanotechnology based chemo-photothermal therapy method.

Authors:  Zahra Alamzadeh; Jaber Beik; Vahid Pirhajati Mahabadi; Ali Abbasian Ardekani; Alireza Ghader; S Kamran Kamrava; Amin Shiralizadeh Dezfuli; Habib Ghaznavi; Ali Shakeri-Zadeh
Journal:  J Photochem Photobiol B       Date:  2019-01-14       Impact factor: 6.252

3.  Bio-inspired development of a dual-mode nanoprobe for MRI and Raman imaging.

Authors:  Kuk-Youn Ju; Sangyeop Lee; Jung Pyo; Jaebum Choo; Jin-Kyu Lee
Journal:  Small       Date:  2014-09-16       Impact factor: 13.281

4.  Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer.

Authors:  Nazila Eyvazzadeh; Ali Shakeri-Zadeh; Reza Fekrazad; Elahe Amini; Habib Ghaznavi; S Kamran Kamrava
Journal:  Lasers Med Sci       Date:  2017-07-03       Impact factor: 3.161

5.  Metal-Organic Frameworks-Derived Carbon Nanoparticles for Photoacoustic Imaging-Guided Photothermal/Photodynamic Combined Therapy.

Authors:  Peng Yang; Ye Tian; Yongzhi Men; Ranran Guo; Haibao Peng; Qin Jiang; Wuli Yang
Journal:  ACS Appl Mater Interfaces       Date:  2018-11-28       Impact factor: 9.229

Review 6.  Strategies to Improve Cancer Photothermal Therapy Mediated by Nanomaterials.

Authors:  Duarte de Melo-Diogo; Cleide Pais-Silva; Diana R Dias; André F Moreira; Ilídio J Correia
Journal:  Adv Healthc Mater       Date:  2017-03-21       Impact factor: 9.933

Review 7.  Cancer nanomedicine: progress, challenges and opportunities.

Authors:  Jinjun Shi; Philip W Kantoff; Richard Wooster; Omid C Farokhzad
Journal:  Nat Rev Cancer       Date:  2016-11-11       Impact factor: 60.716

Review 8.  Metal-Organic Framework (MOF)-Based Drug/Cargo Delivery and Cancer Therapy.

Authors:  Ming-Xue Wu; Ying-Wei Yang
Journal:  Adv Mater       Date:  2017-03-29       Impact factor: 30.849

Review 9.  Polydopamine--a nature-inspired polymer coating for biomedical science.

Authors:  Martin E Lynge; Rebecca van der Westen; Almar Postma; Brigitte Städler
Journal:  Nanoscale       Date:  2011-10-25       Impact factor: 7.790

10.  Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods.

Authors:  Xiaohua Huang; Ivan H El-Sayed; Wei Qian; Mostafa A El-Sayed
Journal:  J Am Chem Soc       Date:  2006-02-15       Impact factor: 15.419

View more
  9 in total

1.  Enhanced photoacoustic imaging in tissue-mimicking phantoms using polydopamine-shelled perfluorocarbon emulsion droplets.

Authors:  Mark Louis P Vidallon; Ekaterina Salimova; Simon A Crawford; Boon Mian Teo; Rico F Tabor; Alexis I Bishop
Journal:  Ultrason Sonochem       Date:  2022-05-18       Impact factor: 9.336

2.  RNA-Seq Based Toxicity Analysis of Mesoporous Polydopamine Nanoparticles in Mice Following Different Exposure Routes.

Authors:  Zihua Huang; Luoyijun Xie; Jifan Zhang; Qiyan Li; Yulin Liu; Xuemei Fu; Miaomiao Yuan; Qingjiao Li
Journal:  Front Bioeng Biotechnol       Date:  2022-04-28

3.  Use of mesoporous polydopamine nanoparticles as a stable drug-release system alleviates inflammation in knee osteoarthritis.

Authors:  Yun Wang; Weiwen Ge; Zhigui Ma; Guangyu Ji; Mingsong Wang; Guangdong Zhou; Xiansong Wang
Journal:  APL Bioeng       Date:  2022-04-21

4.  Mesoporous Polydopamine Nanoparticles Attenuate Morphine Tolerance in Neuropathic Pain Rats by Inhibition of Oxidative Stress and Restoration of the Endogenous Antioxidant System.

Authors:  Yaswanth Kuthati; Prabhakar Busa; Srikrishna Tummala; Vaikar Navakanth Rao; Venkata Naga Goutham Davuluri; Yen-Peng Ho; Chih-Shung Wong
Journal:  Antioxidants (Basel)       Date:  2021-01-29

Review 5.  Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics.

Authors:  Menglu Zhu; Yi Shi; Yifan Shan; Junyan Guo; Xuelong Song; Yuhua Wu; Miaolian Wu; Yan Lu; Wei Chen; Xiaoling Xu; Longguang Tang
Journal:  J Nanobiotechnology       Date:  2021-11-24       Impact factor: 10.435

6.  Chemo-photothermal immunotherapy for eradication of orthotopic tumors and inhibition of metastasis by intratumoral injection of polydopamine versatile hydrogels.

Authors:  Bo Zhuang; Ting Chen; Yueqi Huang; Zhimei Xiao; Yiguang Jin
Journal:  Acta Pharm Sin B       Date:  2021-09-07       Impact factor: 14.903

7.  Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer.

Authors:  Andrea Bistrović Popov; Francesca Melle; Emily Linnane; Cristina González-López; Ishtiaq Ahmed; Badri Parshad; Christoph O Franck; Hassan Rahmoune; Frances M Richards; Daniel Muñoz-Espín; Duncan I Jodrell; David Fairen-Jimenez; Ljiljana Fruk
Journal:  Nanoscale       Date:  2022-05-05       Impact factor: 8.307

Review 8.  PDA-Based Drug Delivery Nanosystems: A Potential Approach for Glioma Treatment.

Authors:  Hao Wu; Min Wei; Yu Xu; Yuping Li; Xue Zhai; Peng Su; Qiang Ma; Hengzhu Zhang
Journal:  Int J Nanomedicine       Date:  2022-08-30

9.  Toxicity Analysis of Mesoporous Polydopamine on Intestinal Tissue and Microflora.

Authors:  Luoyijun Xie; Qiyan Li; Yingying Liao; Zihua Huang; Yulin Liu; Chutong Liu; Leilei Shi; Qingjiao Li; Miaomiao Yuan
Journal:  Molecules       Date:  2022-09-30       Impact factor: 4.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.